154 related articles for article (PubMed ID: 28024835)
1. Leukocytosis and neutrophilia predicts outcome in anal cancer.
Schernberg A; Escande A; Rivin Del Campo E; Ducreux M; Nguyen F; Goere D; Chargari C; Deutsch E
Radiother Oncol; 2017 Jan; 122(1):137-145. PubMed ID: 28024835
[TBL] [Abstract][Full Text] [Related]
2. External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation.
Schernberg A; Huguet F; Moureau-Zabotto L; Chargari C; Rivin Del Campo E; Schlienger M; Escande A; Touboul E; Deutsch E
Radiother Oncol; 2017 Jul; 124(1):110-117. PubMed ID: 28662871
[TBL] [Abstract][Full Text] [Related]
3. Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation.
Schernberg A; Moureau-Zabotto L; Rivin Del Campo E; Escande A; Ducreux M; Nguyen F; Goere D; Chargari C; Deutsch E
Oncotarget; 2017 Feb; 8(7):11579-11588. PubMed ID: 28086222
[TBL] [Abstract][Full Text] [Related]
4. Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer.
Schernberg A; Mezquita L; Boros A; Botticella A; Caramella C; Besse B; Escande A; Planchard D; Le Péchoux C; Deutsch E
PLoS One; 2018; 13(10):e0204490. PubMed ID: 30304046
[TBL] [Abstract][Full Text] [Related]
5. Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy.
Schernberg A; Blanchard P; Chargari C; Ou D; Levy A; Gorphe P; Breuskin I; Atallah S; Caula A; Escande A; Janot F; Nguyen F; Temam S; Deutsch E; Tao Y
Clin Transl Radiat Oncol; 2018 Aug; 12():8-15. PubMed ID: 30073209
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.
Banerjee R; Roxin G; Eliasziw M; Joseph K; Maclean A; Buie WD; Doll C
Dis Colon Rectum; 2013 Sep; 56(9):1036-42. PubMed ID: 23929012
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study.
Kim E; Kim TH; Jung W; Kim K; Chang AR; Park HJ; Koh HK; Hong S; Kim KH; Chang JS; Koom WS; Jang WI; Kim MS
Int J Clin Oncol; 2022 Mar; 27(3):553-562. PubMed ID: 34842994
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilia in locally advanced cervical cancer: A novel biomarker for image-guided adaptive brachytherapy?
Escande A; Haie-Meder C; Maroun P; Gouy S; Mazeron R; Leroy T; Bentivegna E; Morice P; Deutsch E; Chargari C
Oncotarget; 2016 Nov; 7(46):74886-74894. PubMed ID: 27713124
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
10. Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer.
Lerman J; Hennequin C; Etienney I; Abramowitz L; Goujon G; Gornet JM; Guillerm S; Aparicio T; Valverde A; Cattan P; Quéro L
Eur J Cancer; 2020 Dec; 141():143-151. PubMed ID: 33137590
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.
Franco P; Montagnani F; Arcadipane F; Casadei C; Andrikou K; Martini S; Iorio GC; Scartozzi M; Mistrangelo M; Fornaro L; Cassoni P; Cascinu S; Ricardi U; Casadei Gardini A
Radiat Oncol; 2018 May; 13(1):83. PubMed ID: 29720197
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
13. Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial.
Diefenhardt M; Hofheinz RD; Martin D; Beißbarth T; Arnold D; Hartmann A; von der Grün J; Grützmann R; Liersch T; Ströbel P; Grabenbauer GG; Rieger M; Fietkau R; Graeven U; Weitz J; Folprecht G; Ghadimi M; Rödel F; Rödel C; Fokas E;
Int J Cancer; 2019 Oct; 145(8):2282-2291. PubMed ID: 30868576
[TBL] [Abstract][Full Text] [Related]
14. Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal.
Bazan JG; Koong AC; Kapp DS; Quon A; Graves EE; Loo BW; Chang DT
J Nucl Med; 2013 Jan; 54(1):27-32. PubMed ID: 23236018
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy for squamous cell carcinoma of the anal canal: Comparison of one versus two cycles mitomycin-C.
White EC; Goldman K; Aleshin A; Lien WW; Rao AR
Radiother Oncol; 2015 Nov; 117(2):240-5. PubMed ID: 26347494
[TBL] [Abstract][Full Text] [Related]
17. Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer.
Koerber SA; Schoneweg C; Slynko A; Krug D; Haefner MF; Herfarth K; Debus J; Sterzing F; von Knebel Doeberitz M; Prigge ES; Reuschenbach M
Radiother Oncol; 2014 Dec; 113(3):331-6. PubMed ID: 25465729
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
[TBL] [Abstract][Full Text] [Related]
19. Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
[TBL] [Abstract][Full Text] [Related]
20. Anal canal carcinoma treatment results: the experience of a single institution.
El-Haddad M; Ahmed RS; Al-Suhaibany A; Al-Hazza M; Al-Sanae N; Al-Jabbar AA; Hamoud S; Ashaary L; Bazerbashy S; Balaraj K
Ann Saudi Med; 2011; 31(2):158-62. PubMed ID: 21403412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
